David Kelly active positions
| Companies | Position | Start | End |
|---|---|---|---|
ArraVasc Ltd.
 ArraVasc Ltd. Medical SpecialtiesHealth Technology ArraVasc Ltd. develops novel solutions for the treatment of complex coronary artery disease. The private company is based in Ballybrit, Ireland. The Irish company was founded in 2005 by Antonio Colombo, Ascher Shmulewitz. | Director of Finance/CFO | - | - |
Career history of David Kelly
Former positions of David Kelly
| Companies | Position | Start | End |
|---|---|---|---|
| ARYZTA AG | Corporate Officer/Principal | - | - |
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - | - |
Chanelle Pharmaceuticals Manufacturing Ltd.
 Chanelle Pharmaceuticals Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Chanelle Pharmaceuticals Manufacturing Ltd. engages in the development, production, marketing, and distribution of generic animal pharmaceutical products. Its veterinary products include Anthelmintics, Antibiotics, Sedatives, NSAIDs, Cardiovascular, Ectoparasiticides, and Anti-Epileptic drugs. The company was founded on June 14, 1984 and is headquartered in Loughrea, Ireland. | Corporate Officer/Principal | - | - |
Cappella, Inc.
 Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Director of Finance/CFO | - | - |
| Treasurer | - | - |
Statistics
International
| Ireland | 4 |
| United States | 2 |
| Switzerland | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 2 |
| Treasurer | 1 |
Sectoral
| Health Technology | 5 |
| Retail Trade | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| ARYZTA AG | Retail Trade |
| Private companies | 3 |
|---|---|
Cappella, Inc.
Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Health Technology |
ArraVasc Ltd.
ArraVasc Ltd. Medical SpecialtiesHealth Technology ArraVasc Ltd. develops novel solutions for the treatment of complex coronary artery disease. The private company is based in Ballybrit, Ireland. The Irish company was founded in 2005 by Antonio Colombo, Ascher Shmulewitz. | Health Technology |
Chanelle Pharmaceuticals Manufacturing Ltd.
Chanelle Pharmaceuticals Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Chanelle Pharmaceuticals Manufacturing Ltd. engages in the development, production, marketing, and distribution of generic animal pharmaceutical products. Its veterinary products include Anthelmintics, Antibiotics, Sedatives, NSAIDs, Cardiovascular, Ectoparasiticides, and Anti-Epileptic drugs. The company was founded on June 14, 1984 and is headquartered in Loughrea, Ireland. | Health Technology |
- Stock Market
- Insiders
- David Kelly
- Experience
